Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04681794 · ClinicalTrials.gov registry record · NA
Mayo Posture Positivity Power Program for Active and Aging Individuals in Communities
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT04681794: Completed NA study, sponsored by Mayo Clinic.
NCT04681794 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04681794, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The research is designed to answer effectiveness of community-based multimodal intervention programs on physical, mental, cognitive, social, and environmental in active and aging individuals.
Primary Outcome
* Age (continuous), * Race (White, Black, Asian, Pacific Islander, Hispanic/Latino, American Indian) * Marital Status (married, divorced/separated/single, widowed) * Education (less than High School, High School, College, Graduate School) * Height * Weight * Smoking (never, former, current) * Alcohol (intake from wine, beer, and liquor - none, 1-14g/day, \>15g/day.) * For Women Only: Women health questions will be asked for past/present conditions (pregnancy, hormonal treatment, menopause, suppl
Interventions
- OTHER exercise-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
What the finished NCT04681794 record still lists
NCT04681794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which exercise-based intervention is the first listed.
NCT04681794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04681794 about?
NCT04681794 is a clinical study titled "Mayo Posture Positivity Power Program for Active and Aging Individuals in Communities". The research is designed to answer effectiveness of community-based multimodal intervention programs on physical, mental, cognitive, social, and environmental in active and aging individuals.
What is the current status of trial NCT04681794?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2020-12-14. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT04681794?
The interventions under investigation include: exercise-based intervention (OTHER).
Who is sponsoring clinical trial NCT04681794?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04681794's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI